Program 379

Primary tabs

Proposal: 
ZRXPzUvaYBF
Target of Oportunity: 
No
Time Observed: 
0.0
Time Engineering: 
1.75
Time lost technical: 
0.25
Time lost weather: 
12.75
Time lost other: 
0.0
Description: 
Your cash is being counted <a href=" http://teazr.me/07/backyard-patio-stones/ ">ranbaxy eriacta 100</a> An experimental drug for Duchenne muscular dystrophy fromGlaxoSmithKline and Prosensa failed to meet its goal in alate-stage clinical trial, the comp
Primary Investigator: 
VPKqJvPKDeWckV
Email: 
careymyi@usa.net
Institution: 
University of Oklahoma
Instrument: 
CTIO 0.9m CCD Direct
Organization: 
UNC
Total Program Time: 
14.75